Inhibition of Platelet Aggregation by Human Placenta

 

PDF Download Buy Article Permissions and Reprints

Summary

Human placental cytosol inhibits platelet aggregation induced by high doses of collagen. The aim of this study was to investigate whether this anti-aggregating activity was caused only by the presence of various activities already described in the placenta (an ADP-consuming enzyme, a fatty acid cyclooxygenase inhibitor, and a thromboxane synthetase inhibitor) or whether another factor was present.

Heating the cytosol at 50° C for 6 min destroyed the inhibitor of collagen-induced aggregation. ADPase and the AA pathway inhibitors were not modified by this treatment. We therefore show the presence of an additional anti-aggregating factor: it is destroyed by heating at 50° C.

We also tested for the presence of an inhibitor of AA release in the placental cytosol using three different methods (rabbit platelets in PRP, washed rabbit platelets, and NRK fibroblasts) but no inhibition could be evidenced.

We conclude that this new anti-aggregating factor, which is probably a protein, acts neither through AA release inhibition nor AA cascade inhibition.

• References

• 1 Myatt L, Elder MG. Inhibition of platelet aggregation by a placental substance with prostacyclin-like activity. Nature 1977; 268: 159-160
  CrossrefPubMedGoogle Scholar
• 2 Hutton RA, Chow FPR, Craft IL, Dandona P. Inhibition of platelet aggregation in the feto-placental unit and myometrium with particular reference to the ADP-degrading property of placenta. Placenta 1980; 1: 125-130
  CrossrefPubMedGoogle Scholar
• 3 Dembélé-Duchesne MJ, Thaler-Dao H, Chavis C, Crastes de PauletA. Some new prospects in the mechanism of control of arachidonate metabolism in human placenta and amnion. Prostaglandins 1981; 22: 979-1002
  CrossrefPubMedGoogle Scholar
• 4 Dembélé-Duchesne MJ, Thaler-Dao H, Chavis C, Crastes de PauletA. The human placental anti-aggregating factor is neither prostacyclin, nor a prostacyclin metabolite. Prostaglandins 1982; 24: 701-714
  CrossrefPubMedGoogle Scholar
• 5 Barradas MA, Craft IL, Dandona P, Jeremy JY. Does the human placenta produce prostacyclin?. J Physiol 1983; 336: 77P
  PubMedGoogle Scholar
• 6 Lewis GP, Watts IS. Prostaglandin endoperoxides, thromboxane A₂ and adenosine diphosphate in collagen-induced aggregation of rabbit platelets. Br J Pharmacol 1982; 75: 623-631
  CrossrefPubMedGoogle Scholar
• 7 Harrowing PD, Williams KI. Homogenates of rat placenta contain a factor(s) which inhibits uterine arachidonic acid metabolism. Br J Pharmacol 1979; 67: 482-483
  PubMedGoogle Scholar
• 8 Duchesne MJ, Thaler-Dao H, Crastes de PauletA. Prostaglandin synthesis in human placenta and fetal membranes. Prostaglandins 1978; 15: 19-42
  CrossrefPubMedGoogle Scholar
• 9 Aster RH, Jandl JH. Platelet sequestration in man. I. Methods. J Lab Clin Invest 1964; 43: 843-855
  PubMedGoogle Scholar
• 10 Chignard M, Le Couedic JP, Vargaftig BB, Benveniste J. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents. Br J Haematol 1980; 46: 455-464
  CrossrefPubMedGoogle Scholar
• 11 Holmsen H, Holmsen I, Bernardsen A. Microdetermination of adenosine diphosphate and adenosine triphosphate in plasma with the firefly luciferase system. Anal Biochem 1966; 17: 456-473
  CrossrefPubMedGoogle Scholar
• 12 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem 1951; 193: 265-275
  PubMedGoogle Scholar
• 13 De Larco JE, Todaro GJ. Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation. J Cell Physiol 1978; 94: 335-342
  CrossrefPubMedGoogle Scholar
• 14 Saeed SA, McDonald-Gibson WJ, Cuthbert J, Copas JL, Schneider C, Gardiner PJ, Butt NM, Collier HOJ. Endogenous inhibitor of PG synthetase. Nature 1977; 270: 32-36
  CrossrefPubMedGoogle Scholar
• 15 Brennecke SP, Humphreys J, Turnbull AC, Mitchell MD. Assay of plasma endogenous inhibitor(s) of PG synthetase using an enzyme incubation-radioimmunoassay method. Prostaglandins, Leucotrienes Med 1982; 8: 615-634
  PubMedGoogle Scholar
• 16 Saeed SA, Strickland DM, Young DC, Dang A, Mitchell MD. Inhibition of prostaglandin synthesis by human amniotic fluid obtained during labor. J Clin Endocrinol Metab 1982; 55: 801-803
  CrossrefPubMedGoogle Scholar
• 17 Harrowing PD, Williams KI. Influence of blood elements on arachidonic acid metabolism in the pregnant uterus. In: Prostacyclin in pregnancy. Lewis PJ, Moncada S, O’Grady J. (Eds). Raven Press; New York: 165-1982
  Google Scholar
• 18 Shemesh M, Hansel W, Strauss III JF. Modulation of bovine placental prostaglandin synthesis by an endogenous inhibitor. Endocrinology 1984; 115: 1401-1405
  CrossrefPubMedGoogle Scholar
• 19 Blatt WF, Dravid A, Michaels AS, Nelson L. Solute polarization and cake formation in membrane ultrafiltration: causes, consequences, and control techniques. In: Membrane Science and Technology. Flinn JE. (Ed). 47-97 Plenum Press; New York: 1970
  CrossrefGoogle Scholar
• 20 Kinlough-Rathbone RL, Packham MA, Reimers HJ, Cazenave JP, Mustard JF. Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23187. J Lab Clin Med 1977; 90: 707-719
  PubMedGoogle Scholar